Department of Oncology, Shaare Zedek Cancer Center, Jerusalem, Israel.
Department of Counseling Psychology, Santa Clara University, Santa Clara, California.
Cancer. 2022 Jan 15;128(2):401-409. doi: 10.1002/cncr.33907. Epub 2021 Oct 6.
Hopefulness, whether inherently present (dispositional hope) or augmented (by enhancement techniques), may affect outcomes. This study was performed to determine the association of dispositional hope with survival among patients diagnosed with advanced cancer.
Data from ENABLE (Educate, Nurture, Advise, Before Life Ends), a palliative care intervention, were reanalyzed to determine the association of higher dispositional hope and patient survival. This was a secondary analysis of data combined from the ENABLE II and ENABLE III randomized controlled trials (RCTs) with respect to dispositional hope and survival. A dispositional hope index was created from 3 hope items from 2 validated baseline questionnaires. Dispositional hope and survival data were collected during the 2 RCTs. In ENABLE II, participants were randomly assigned to the ENABLE intervention or to usual care. In ENABLE III, participants were randomly assigned to receive the intervention immediately or 12 weeks after enrollment.
In all, 529 persons were included in Cox proportional hazards regression analyses to model the effects of dispositional hope on survival. An initial analysis without covariates yielded a significant effect of hope (Wald statistic, 8.649; hazard ratio, 0.941; confidence interval, 0.904-0.980; P = .003), such that higher dispositional hope was associated with longer survival. In a subsequent analysis that included all covariates, the effect of dispositional hope approached statistical significance (Wald statistic, 2.96; hazard ratio, 0.933; confidence interval, 0.863-1.010; P = .085).
Higher levels of dispositional hope were associated with longer survival in patients with advanced cancer. Prospective trials are needed to determine the effects of dispositional and augmented hope on the outcomes of patients with advanced cancer.
希望无论是固有存在的(特质性希望)还是通过增强技术增强的,都可能影响结局。本研究旨在确定特质性希望与诊断为晚期癌症患者的生存之间的关系。
对姑息治疗干预措施 ENABLE 研究的数据进行了重新分析,以确定特质性希望与患者生存之间的关系。这是对来自 ENABLE II 和 ENABLE III 随机对照试验(RCT)中特质性希望和生存数据的二次分析。特质性希望指数是由 2 个经过验证的基线问卷中的 3 个希望项目创建的。特质性希望和生存数据是在这 2 个 RCT 中收集的。在 ENABLE II 中,参与者被随机分配到 ENABLE 干预组或常规护理组。在 ENABLE III 中,参与者被随机分配到立即接受干预或在入组后 12 周接受干预。
共有 529 人被纳入 Cox 比例风险回归分析模型,以评估特质性希望对生存的影响。在没有协变量的初始分析中,希望具有显著的效果(Wald 统计量,8.649;风险比,0.941;置信区间,0.904-0.980;P =.003),即特质性希望越高,生存时间越长。在包含所有协变量的后续分析中,特质性希望的作用接近统计学意义(Wald 统计量,2.96;风险比,0.933;置信区间,0.863-1.010;P =.085)。
在晚期癌症患者中,特质性希望水平越高,生存时间越长。需要前瞻性试验来确定特质性和增强性希望对晚期癌症患者结局的影响。